• Skip to content
  • Skip to navigation

Grant Thornton Australia

Grant Thornton uses cookies to monitor the performance of this website and improve user experience.

If you are happy to accept cookies from this site, please check the box.

To find out more about cookies, what they are and how we use them, please see our privacy notice, which also provides information on how to delete cookies from your hard drive.

How to be COVIDSafe when visiting Grant Thornton offices. Find out how

Global site
  • Global site
  • Algeria
  • Botswana
  • Cameroon
  • Egypt
  • Ethiopia
  • Gabon
  • Guinea
  • Kenya
  • Libya
  • Malawi
  • Mauritius
  • Morocco
  • Nigeria
  • Namibia
  • Senegal
  • South Africa
  • Togo
  • Tunisia
  • Uganda
  • Zambia
  • Zimbabwe
  • Anguilla
  • Antigua
  • Argentina
  • Aruba, Bonaire, Curacao and St. Maarten
  • Bahamas
  • Barbados
  • Bolivia
  • Brazil
  • British Virgin Islands
  • Canada LLP
  • Canada RCGT
  • Cayman Islands
  • Chile
  • Colombia
  • Costa Rica
  • Dominica
  • Ecuador
  • El Salvador
  • Grenada
  • Guatemala
  • Honduras
  • Mexico
  • Montserrat
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • Puerto Rico
  • St Kitts
  • St Lucia
  • St Vincent and the Grenadines
  • Trinidad & Tobago
  • United States
  • Uruguay
  • Venezuela
  • Turks & Caicos
  • Afghanistan
  • Australia
  • Bangladesh
  • Cambodia
  • China
  • Hong Kong
  • India
  • Indonesia
  • Japan
  • Korea
  • Malaysia
  • Mongolia
  • Myanmar
  • New Zealand
  • Pakistan
  • Philippines
  • Singapore
  • Taiwan
  • Thailand
  • Vietnam
  • Albania
  • Armenia
  • Austria
  • Azerbaijan
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Channel Islands
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Georgia
  • Germany
  • Gibraltar
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Isle of Man
  • Israel
  • Italy - Bernoni
  • Italy - Ria
  • Kazakhstan
  • Kosovo
  • Kyrgyzstan
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malta
  • Moldova
  • Monaco
  • Netherlands
  • Northern Ireland
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Tajikistan
  • Turkey
  • Ukraine
  • UK
  • Uzbekistan
  • Bahrain
  • Egypt
  • Jordan
  • Kuwait
  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates
  • Yemen
  • Lebanon
Grant Thorton Logo

Grant Thornton Logo Grant Thornton Logo

Contact us
  • Insights
  • Services
  • Industries
  • Meet our people
  • Careers
  • News centre
  • Locations
  • About us
  • Audit
  • Tax
  • Private Advisory
  • Financial Advisory
  • Grant Thornton Consulting
  • Asia
Audit Home
  • Audit methodology
  • Audit technology
  • Financial reporting advisory
Tax Home
  • Corporate tax
  • Employee equity reward schemes
  • Fringe benefits tax
  • Global mobility services
  • GST & indirect tax
  • International tax
  • Payroll assurance
  • Research & development
  • Tax compliance
  • Tax governance & risk management
  • Tax in mergers & acquisitions
  • Tax lawyers
  • Transfer pricing
Private Advisory Home
  • Family Business Consulting
  • Family office services
  • Private wealth
  • Superannuation
Financial Advisory Home
  • Corporate finance
  • Debt advisory
  • Forensic consulting
  • Payments advisory
  • Restructuring advisory
Grant Thornton Consulting Home
  • Business risk
  • Human capital
  • Performance improvement
  • Strategy & growth
  • Technology consulting
  • GNC Group Consulting
Asia Home
  • China practice
  • India practice
  • Japan practice
  • Agribusiness, food & beverage
  • Automotive dealers
  • Education
  • Energy & resources
  • Financial services
  • Health & aged care
  • Life sciences
  • Manufacturing
  • Not for Profit
  • Professional services
  • Public sector
  • Real estate & construction
  • Retail & consumer products
  • Technology & media
Agribusiness, food & beverage Home
Bite Size Dealtracker Food, Beverage & Agribusiness industry insights
Key insights for the Australian Food, Beverage & Agribusiness industry.
Financial services Home
  • Banking
  • Fintech
  • Private Health Insurance
  • Superannuation
  • Asset management
  • BEAR FAQs
  • Open banking
Royal Commission wrap up Top 10 things for Financial Services providers
Eleven months on from the first round of hearings for the Royal Commission into Misconduct in the Banking, Superannuation and Financial Services Industry, Commissioner Hayne’s final report has been released.
Health & aged care Home
Aged Care Royal Commission Perspectives on the Future of Ageing
Transitions in ageing are not consistent and systematic as they are described by our ageing systems. Sometimes they are incremental, sometimes accidental, sometimes monumental, and they are always personal. We can create something better.
Life sciences Home
Biotechnology Industry Position survey Australia's biotechnology industry drives economic growth
The 2019 Biotechnology Industry Position survey conducted by Ausbiotech and supported by Grant Thornton has revealed that new technologies across regenerative medicine and medicinal cannabis are disrupting the industry, and Australia's global strength in clinical trials continues to drive contributions to the economic and social fabric of the country.
Manufacturing Home
mid-sized business report Manufacturing is critical to our economy – how can we support the sector?
Although the knock-on effects of the Australian automotive industry exiting our country are yet to be fully understood, the industry is evolving, and manufacturing continues to be a major employer and critical to our overall economy.
Not for Profit Home
NATIONAL OUTCOMES MEASUREMENT PROGRAM A practical framework
Royal Commissions and federal budgets are critical things for Nonprofit human service providers to be thinking about at this point in time.
Real estate & construction Home
mid-sized business report Supporting affordable housing requires planning, certainty – and tax reform
There is a lot of noise around the property sector at the moment – and it’s not all positive. Prices are down – but this shouldn’t be a surprise when some markets (namely Sydney & Melbourne) saw unprecedented hikes in recent years.
Retail & consumer products Home
GNC Group Consulting The Technology Trap: Online innovation in retail
I recently attended the NRF Retail Big Show in New York, an overwhelming smorgasbord of retail technology and new store concepts.
Technology & media Home
  • Telecommunications
Scaling-up for Growth From start-up to scale-up
Navigating the complexities of growth and maintaining previous success is a challenge for all mid-size businesses.
  • Working at Grant Thornton
  • Student opportunities
  • Experienced careers
  • Contact us
Working at Grant Thornton Home
  • Flexibility
  • Your career and development
  • Diversity and inclusion
  • In the community
  • What we offer you
Student opportunities Home
  • Graduates
  • Vacationer Program
  • The application process
  • FAQs
  • Student application tips and tricks
Experienced careers Home
  • Client spotlight
  • Grant Thornton Australia | Audit, Tax and Advisory
  • Client alerts
  • 2016
  • APRA prudential policy outlook for Private Health Insurance

APRA prudential policy outlook for Private Health Insurance

03 Aug 2016
  • APRA prudential policy outlook for Private Health Insurance

APRA have released their prudential policy outlook for Private Health Insurance (PHI) following consultation with the industry and other stakeholders.

Grant Thornton welcomes APRA’s commitment to consultation with the industry and looks forward to our involvement in shaping the future of the PHI prudential framework.

Key messages:

  • It is reassuring for the PHI industry to note that from APRA’s observation of the industry to date, they have no significant prudential concerns and therefore see no urgency to modify the PHI prudential framework.
  • APRA is committed to ensuring that the PHI prudential framework remains fit for purpose and relevant to the PHI industry.
  • APRA has re-iterated that it understands that PHI is different and that in aligning the prudential requirements a one-size fits all approach will not be taken. Where relevant specific PHI requirements will be considered to ensure the framework remains fit for purpose for the PHI industry. It is clear that APRA intends to use as a starting point the prudential frameworks as they apply to other regulated industries. As a result, Grant Thornton expects that the core principles from existing prudential standards and best practice from other regulated industries are likely to be used in deriving the new PHI prudential framework. Whilst harmonisation is not the main goal, they do see significant benefits particularly for those entities that operate across APRA regulate industries.
  • APRA is mindful of not burdening the industry with significant change and at a measure pace will be inviting submission to consultation with industry and stakeholders. We encourage your leadership team to take advantage of the consultation process to ensure that your individual specific circumstances are considered by APRA as outcomes may be difficult to change once APRA’s position is finalised.

Prior to the release of this letter, the last of the roundtables were held with APRA and the Appointed Auditors of private health insurers. At this meeting the Auditors had the opportunity to discuss the three phase plan and APRA's supervisory role moving forward.

APRA in our discussion over role in relation to policies, (such as sustainability and premium setting) noted that these are outside their mandate and are dealt with by the Department of Health.  However insurers should be aware that under their mandate they will be interested observers of policy. In particular assessing the impact any changes in policies may have on their ability to comply with prudential requirements that may give rise to prudential concerns.

Phase one: Risk

Risk Management – the Thematic reviews of 18 health insurers have been completed with respect to risk management.  APRA’s feedback from these reviews is that overall the industry is more advanced than they anticipated and are well progressed in the implementation of risk management arrangements. It was also clear from our discussion that you can anticipate the core principles of CPS 220 will be introduced to the PHI prudential framework. We recommend that leadership teams familiarise themselves with the CPS 220 and the related practice guide CPG 220 Risk Management.

Outsourcing and Business Continuity – APRA acknowledge there is significant concentration risk particularly in relation to IT service providers. Whilst this has its benefits it does also pose significant risk. As highlighted in the letter a broader cross industry review will commence in 2017. Grant Thornton recommends a submission to APRA to ensure any potential impacts on your industry are brought to APRA’s attention and the final position does not inadvertently disadvantage the health insurance industry, in its alignment of these standards.

Phase two: Governance

Audit and Related Matters – this was a key topic of discussion. APRA’s view was very clear that they want to gain greater comfort over compliance by private health insurers with prudential standards, consistent with the other APRA regulated industries. An audit specific prudential standard is likely to be introduced encompassing the external audit function.  This will include the requirement for independent assurance to be provided over prudential matters however the full extent of this additional assurance is yet to be determined.

In our experience, we expect this to encompass elements of assurance over the effectiveness of internal controls in addressing compliance with prudential requirements as well as an opinion on compliance with the Prudential Standards. As private health insurers move to this new level of regulation and reporting compliance, we welcome the opportunity to discuss best practice leveraging from our extensive experience with other regulated bodies.

Phase three: Capital

A cautious message is currently being conveyed by APRA so as to not disrupt the current macro environment. APRA commented that they do not see this as an area of immediate priority in the medium term and they don’t see any fundamental weaknesses in the current Capital Management Plan (CMP).  APRA noted that in their view there is not much difference between the current CMP and Internal Capital Adequacy Assessment Process (ICAAP) in place for other regulated entities. There is likely to be little change proposed until significant groundwork has been made on risk and governance.

Given the measured pace for implementing changing and the drive for consultation by APRA, the industry is well placed to participate in shaping the future of the PHI prudential framework.

Overall, the consultation process and outlook APRA has put forward is a positive move and we look forward to our ongoing involvement in the process. It’s very clear APRA will be seeking to leverage from comparable prudential standards within other regulated industries. We welcome the opportunity to discuss any of the prudential standards and likely changes. including best practice from our extensive experience with other APRA regulated industries and our experience in providing assurance over prudential matters.

 

For more information, contact:

Alison Sheridan
Alison Sheridan
Partner Sydney
Email address https://au.linkedin.com/pub/alison-sheridan/21/4a2/863 Alison Sheridan VCard
View full profile
Share this page
  • Share this page on Facebook LinkedIn
  • Share this page on Twitter Twitter
  • Share this page on LinkedIn LinkedIn
  • Share this page on Wechat WeChat
  • Share this page via email Email
  • Follow us on youtube
  • Follow us on linkedin
  • Follow us on twitter
  • Follow us on facebook
Connectclose
  • Contact us
  • Locations
  • Meet our people
  • Subscribe
  • Staff portal
Aboutclose
  • About us
  • Careers
  • News centre
  • Client alerts
  • Grant Thornton Foundation
  • Grant Thornton Affinity
Legalclose
  • Privacy
  • Compliance and ethics
  • Disclaimer
  • Site map

© 2021 Grant Thornton Australia Limited – All rights reserved

    • EN
    • Contact us